Abstract
Group sequential designs are important tools for clinical trials with interim monitoring plans. Recently, asymmetric group sequential designs with non binding rules are applied to clinical trials of many disease areas including oncology. In this article, we study boundary calculations and sample size determination for these designs with interim statistics under both standard Brownian motion (BM) and fractional Brownian motion (FBM). Power family spending functions, including Pocock and O'Brien-Fleming design types, are considered for these calculations. We use clinical trial examples to show how to design such trials under BM and FBM for efficacy and futility monitoring.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
